XML 59 R46.htm IDEA: XBRL DOCUMENT
v3.23.1

Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022
--- | --- | ---
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Other | $ 2,191 | $ 3,080
Total accrued expenses and other current liabilities | 12,393 | 14,764
Supply Agreement | Vaxcyte |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Collaboration and license agreements and supply agreement accruals | 5,274 | 4,830
CMO |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Collaboration and license agreements and supply agreement accruals | 2,404 | 3,900
Clinical Trials |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Collaboration and license agreements and supply agreement accruals | $ 2,524 | $ 2,954

X
- Definition Accrued expenses and other current liabilities. + References No definition available. + Details
Name: | stro_AccruedExpensesAndOtherCurrentLiabilities
Namespace Prefix: | stro_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Collaboration and license agreements and supply agreement accruals current. + References No definition available. + Details
Name: | stro_CollaborationAndLicenseAgreementsAndSupplyAgreementAccrualsCurrent
Namespace Prefix: | stro_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_OtherLiabilitiesCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=stro_SupplyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=stro_VaxcyteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=stro_CmoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=stro_ClinicalTrialsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |